Printer-friendly version

This study is the fifth installment in an ongoing project aimed at understanding and, more importantly, documenting the public policies that contribute to, and sustain, positive investment climates. The study assesses empirically and then ranks the investment climates of the Canadian provinces based on a number of public policies that were identified by investment managers as contributing to a positive investment climate. The Fraser Institute surveyed senior investment managers in Canada on a variety of issues from 1998 to 2004 and these surveys were used to assess and rank the investment climate of the Canadian provinces. Canadian Provincial Investment Climate: 2010 Report uses the results from those surveys to create a quantifiable index of provincial investment climates.

Printer-friendly version

This report presents an overview of North America’s natural gas resource endowment, recent historical gas price patterns, and the continental natural gas supply, demand, and out look. It then examines the uncertainties and risks that constrain the development of natural gas production and transportation facilities, and identifies barriers to such investment.

Printer-friendly version

This is the seventh report on economic freedom in the Arab world. The first was published by the same authors in the Arab World Competitiveness Report 2005 (Lopez-Claros and Schwab, 2005). The second and subsequent editions were published by the International Research Foundation (IRF) of Oman and the Fraser Institute. In 2008, the Friedrich Naumann Foundation for Liberty, Cairo office, also became a co-publisher.

Printer-friendly version

This paper compares the economic performance of Canada’s health insurance system against the health insurance systems of 27 other countries that are members of the Organisation for Economic Co-operation and Development (OECD). Economic performance is defined by the availability of medical resources and the output of medical services, as well as the associated level of national health spending as a percentage of GDP. The value for money produced by a country’s health insurance system is defined relative to the economic performance of the health insurance systems of its international peers . Our analysis uses the most recent internationally comparable data reported to the OECD by its member countries, current to the year 2007, for the 28 OECD countries reporting sufficient data for comparison.

Printer-friendly version
Measuring the Fiscal Performance of Canada's Premiers

Since there is no measure of how provincial premiers are performing, it is difficult for Canadians to hold the premiers accountable for the relative performance of their fiscal policies. This report provides Canadians with an objective, empirical assessment of how Canada’s premiers have managed their province’s public finances and whether they have pursued sound long-term economic policies.

Printer-friendly version

Since 2005, this study has regularly compared Canadian and American retail prices for an identical group of the 100 most commonly prescribed brand-name (mostly patented) drugs and the 100 most commonly prescribed generic drugs in Canada. This year’s study focuses exclusively on the price difference between the two countries for the 100 generic drugs that were most commonly prescribed in Canada in 2008.

Printer-friendly version

The Misguided War against Medicines 2010 examines all of the ways in which spending on drugs may contribute to the overall growth in total government health spending. The evidence suggests that neither patented medicines in particular, nor prescription drugs in general, can be blamed for the unsustainable growth rates of government health spending.